The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transfer of Listing Segment

24 Apr 2014 11:32

RNS Number : 4331F
Jardine Matheson Hldgs Ltd
24 April 2014
 



Transfer of Listing Segment of Jardine Matheson Holdings Limited, Jardine Strategic Holdings Limited, Dairy Farm International Holdings Limited, Hongkong Land Holdings Limited and Mandarin Oriental International Limited (the 'Group Companies') on the London Stock Exchange24th April 2014 - On 6th March 2014 the Group Companies issued circulars to their respective shareholders (the 'Shareholder Circulars') relating to the transfer of the listing segment of their equity shares from premium listing (commercial company) to standard listing (shares) on the Main Market of London Stock Exchange (the 'Transfers').At the respective Special General Meetings of the Group Companies, which were each held on 8th April 2014, the requisite shareholder approvals were given authorizing the Transfers as set out in the following summary of proxy votes:

Special Resolution

Proxy Votes

Votes

For

Votes

Against

Votes

Withheld

Total

Jardine Matheson

Holdings Limited

594,182,825

16,945,292

9,714,353

620,842,470

Jardine Strategic

Holdings Limited

983,097,715

49,168,039

16,354,990

1,048,620,744

Dairy Farm International Holdings Limited

1,195,562,487

60,843,808

0

1,256,406,295

Hongkong Land

Holdings Limited

1,621,896,637

205,169,663

86,815,506

1,913,881,806

Mandarin Oriental

International Limited

860,679,806

1,759,006

1,603,361

864,042,173

Accordingly, each of the Group Companies has now applied to the UK Listing Authority to approve the Transfers with effect from 27th May 2014.Following the Transfers, the trading arrangements for the shares of each of the Group Companies will remain unchanged. The governance arrangements that will continue to apply after the Transfers are fully set out in the Shareholder Circulars, which can be found on the respective Group Companies' websites. These arrangements include additional governance principles the Group Companies intend to maintain that are outlined in section 4 of the Chairman's Letters in the Shareholder Circulars and are also set out in the Notes below.NotesGovernance PrinciplesA detailed summary of the differences between the UK Listing Rules that are currently applicable to companies with a standard listing and those with a premium listing is contained in Part III of the Shareholder Circulars. The principal differences are that the UK Listing Rules in respect of significant transactions and related party transactions (including the requirement for shareholder approval in certain instances), pre-emption and the need to comply or explain non-compliance with the UK Code will no longer apply to the Group Companies. Notwithstanding the differences between the UK Listing Rules applicable to premium and standard listed companies, the Group Companies set out in their Shareholder Circulars that they each intended to maintain certain governance principles, as follows: 1. When assessing a Significant Transaction, being a larger transaction which would be classified as a class 1 transaction under the existing provisions of the UK Listing Rules, having regard to the basis on which such provisions are currently applied to the Company, the Company will engage an independent financial adviser to provide a fairness opinion on the terms of the transaction.2. In the event of a Related Party Transaction, being a transaction with a related party which would require a sponsor to provide a fair and reasonable opinion under the existing provisions of the UK Listing Rules, having regard to the basis on which such provisions are currently applied to the Company, the Company will engage an independent financial adviser to confirm that the terms of the transaction are fair and reasonable as far as the shareholders of the Company are concerned.3. Further, as soon as the terms of a Significant Transaction or a Related Party Transaction are agreed, an announcement will be issued by the Company providing such details of the transaction as are necessary for investors to evaluate the effect of the transaction on the Company.4. At each annual general meeting, the Company will continue to seek shareholder approval to issue new shares on a non-pre-emptive basis, in line with the authority currently sought at each annual general meeting.5. The UK Disclosure and Transparency Rules will require the Company to include in the corporate governance statement in its annual report information regarding the corporate governance arrangements applied beyond the requirements under local law. The Company will therefore continue to disclose its corporate governance arrangements in its annual report in a manner consistent with past practice.6. The Company will continue to adhere to its Securities Dealing Rules which follow the UK Model Code.7. The Company will continue its current policies and practices in respect of risk management and internal controls.

- end -

 

For further information, please contact:Asia

The Jardine Matheson Group

Neil M McNamara 852 2843 8227

 

UK

Brunswick

Tom Burns / Richard Jacques 44 (0) 20 7404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGZDGDGGDZM
Date   Source Headline
23rd Jan 201910:38 amRNSShares Purchase
22nd Jan 201910:48 amRNSShares Purchase
21st Jan 201911:21 amRNSShares Purchase
20th Dec 201811:34 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:12 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
12th Oct 201812:00 pmRNSShares Purchase
10th Oct 201810:45 amRNSShares Purchase
10th Oct 201810:12 amRNSDirector/PDMR Shareholding
9th Oct 201811:03 amRNSShares Purchase
5th Oct 201810:47 amRNSShares Purchase
5th Oct 201810:36 amRNSAdditional Listing
4th Oct 201811:30 amRNSShares Purchase
3rd Oct 201811:14 amRNSShares Purchase
2nd Oct 201811:36 amRNSShares Purchase
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
26th Sep 201810:10 amRNSDividend
21st Sep 201811:33 amRNSDividend
29th Aug 201810:08 amRNSCirc re. Scrip Dividend Scheme
17th Aug 201810:26 amRNSDF Partnership With Robinsons Receive PCC Approval
27th Jul 201810:47 amRNSHalf-year Report
27th Jul 201810:41 amRNSHalf-year Report
26th Jul 201811:07 amRNSPT Astra International Tbk Half Year Report
26th Jul 201810:06 amRNSHalf-year Report
26th Jul 201810:06 amRNSHalf-year Report
26th Jul 201810:06 amRNSHalf-year Report
25th Jul 201810:35 amRNSFirst Half of 2018 Results of PT Hero
28th Jun 201810:11 amRNSNotice of 2018 Half-Yearly Results
7th Jun 20187:00 amRNSMandarin Oriental International Ltd Announcement
31st May 201810:25 amRNSTotal Voting Rights
16th May 201810:14 amRNSDirector/PDMR Shareholding
11th May 201810:10 amRNSAdditional Listing
10th May 20185:06 pmRNSDirectorate Change
10th May 20185:05 pmRNSResult of AGM
10th May 20185:05 pmRNSNon-Routine Resolutions submitted via NSM
10th May 201812:34 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.